Balance Training for Airflow Obstruction, Chronic

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Airflow Obstruction, Chronic
Balance Training - Other
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test if balance training can help people with COPD and identify which patients respond best to this type of training.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Airflow Obstruction, Chronic

Study Objectives

2 Primary · 2 Secondary · Reporting Duration: 8 weeks

4 weeks
Change in Brief Balance Evaluation Systems Test total score baseline to 4 weeks
Global Rating of Change in Balance after 4 weeks
8 weeks
Change in Brief Balance Evaluation Systems Test total score baseline to 8 weeks
Global Rating of Change in Balance after 8 weeks

Trial Safety

Safety Progress

1 of 3

Other trials for Airflow Obstruction, Chronic

Trial Design

2 Treatment Groups

Breathing and Stretching Exercises
1 of 2
Balance Training
1 of 2
Active Control
Experimental Treatment

88 Total Participants · 2 Treatment Groups

Primary Treatment: Balance Training · No Placebo Group · N/A

Balance Training
Other
Experimental Group · 1 Intervention: Balance Training · Intervention Types: Other
Breathing and Stretching Exercises
Other
ActiveComparator Group · 1 Intervention: Breathing and Stretching Exercises · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 8 weeks

Who is running the clinical trial?

Texas Woman's UniversityLead Sponsor
77 Previous Clinical Trials
5,299 Total Patients Enrolled
Christopher A Brown, PT, DPTPrincipal InvestigatorTexas Woman's University

Eligibility Criteria

Age 18+ · All Participants · 7 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 17th, 2021

Last Reviewed: October 9th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

Who else is applying?

What state do they live in?
Texas66.7%
Ohio16.7%
Kansas16.7%
What portion of applicants met pre-screening criteria?
Met criteria100.0%
References